AWH News and Press, Aspira Women's Health Inc. From 04/29/22

AUSTIN, Texas, April 29, 2022 (GLOBE NEWSWIRE) -- Aspira Women’s Health, Inc. (Nasdaq: AWH), a bioanalytical-based women’s health company, today announced that the company will report its financial results for the first quarter ended March 31, 2022 before the market open on We...

Shares of Aspira Women's Health Inc. (NASDAQ:AWH) traded today at $54.46, eclipsing its 52-week high. This new high was reached on above average trading volume as 32 million shares traded hands, while the average 30-day volume is approximately 429,000 shares. Aspira Womens Health Inc is ...

Shares of Aspira Women's Health Inc. (NASDAQ:AWH) traded today at $54.46, eclipsing its 52-week high. So far today approximately 31.9 million shares have been exchanged, as compared to an average 30-day volume of 433,000 shares. In the past 52 weeks, shares of Aspira Women's Health Inc. ...

Image source: The Motley Fool. Aspira Women's Health Inc. (NASDAQ: AWH) Q4 2021 Earnings Call Mar 23, 2022 , 8:30 a.m. ET Operator Continue reading For further details see: Aspira Women's Health Inc. (AWH) Q4 2021 Earnings Call Transcript...

Aspira Women's Health Inc. (AWH) Q4 2021 Results Conference Call March 23, 2022 08:30 AM ET Company Participants Valerie Palmieri - Executive Chair of the Board Nicole Sanford - President and Chief Executive Officer Rob Beechey - Chief Financial Officer Conference Call Participants Ross Osbor...

Aspira Women’s Health press release (NASDAQ:AWH): Q4 GAAP EPS of -$0.08 beats by $0.01. Revenue of $1.85M (+27.6% Y/Y) misses by $0.05M. Shares -1.89% PM. For further details see: Aspira Women’s Health GAAP EPS of -$0.08 beats by $0.01, revenue of $1.85M misses by $0.05M ...

Total Revenue Increased 46% to $6.8 million; OVA1 Volume Grew 28% to 17,359 Units Exercise of option in the Harvard Dana-Farber Cancer Institute Collaboration Leadership and Board appointments implemented in First Quarter of 2022 Conference Call and Webcast sched...

AUSTIN, Texas, March 15, 2022 (GLOBE NEWSWIRE) -- Aspira Women’s Health, Inc. (Nasdaq: AWH), a bioanalytical-based women’s health company, today announced that the company will report its financial results for the year ended December 31, 2021 before the market open on Wednesda...

AUSTIN, Texas, Feb. 28, 2022 (GLOBE NEWSWIRE) -- Aspira Women’s Health Inc. (Nasdaq: AWH), a bioanalytical-based women’s health company, today announced the appointment of Celeste Fralick, Ph.D., to its Board of Directors, effective February 23, 2022. Dr. Fralick is an a...

Aspira Women’s Health (NASDAQ:AWH) appointed Nicole Sandford as President and CEO and Valerie Palmieri as Executive Chair of the Board; Valerie served as CEO for eight years. A seasoned professional with 30+ years of experience in leading businesses as an innov...